Design, Synthesis of Some New N-(2-fluoro-4-morpholin-4-yl-phenyl)-Substituted-Benzamide Derivatives and Screening of Their Microbial Activities

References

• Merck Index, Review of Morpholine and Its Derivatives, 12th ed. (New Jersey: Merck & Co, Whitehouse Station, 1996), 1074–5.
   Google Scholar
• M. Pushpak and M. Bekington, “Synthesis of Substituted 4-(3-Alkyl-1,2,4-Oxadiazol-5ylmethyl)-3,4-Dihydro-2H-1,4-benzoxazinesand4-(1H-Benzimidazol-2-Ylmethyl)-3,4-Dihydro-2H-1,4benzoxazines,” Tetrahedron Letters 47, no. 44 (2006): 7823–6.
   Web of Science ®Google Scholar
• G. Zhou, N. Zorn, P. Ting, R. Aslanian, M. Lin, J. Cook, J. Lachowicz, A. Lin, M. Smith, J. Hwa, et al. “Development of Novel Benzomorpholine Class of Diacylglycerol Acyltransferase I Inhibitors,” ACS Medicinal Chemistry Letters 5, no. 5 (2014): 544–9.
   PubMed Web of Science ®Google Scholar
• B. Achari, B.M. Sukhendu, P. Dutta, and C. Chowdhury, “Perspectives on 1, 4-Benzodioxions,1, 4-Benzoxazines and Their 2, 3- Dihydro Derivatives,” Synlett 14, (2004): 2449–67.
   Google Scholar
• P. Panneerselvam, R.V. Pradeepchandran, and S.K. Sreedhar, “Synthesis, Characterization and Biological Activities of Novel 2- Methyl-Quinazolin-4(3H)-Ones,” Indian Journal of Pharmaceutical Sciences 65, no. 3 (2003): 268–73.
   Google Scholar
• G.R. Brown, A.J. Foubister, and D. Stribling, “Synthesis and Resolution of 3-Substituted Morpholine Appetite Suppressants and Chiral Synthesis via o-Arylhomoserines,” Journal of the Chemical Society, Perkin Transactions 1, (1987): 547.
   Google Scholar
• A.H. El-Masry, H.H. Fahmy, and A.S.H. Abdelwahed, “Synthesis and Antimicrobial Activity of Some New Benzimidazole Derivatives,” Molecules 5, no. 12 (2000): 1429–38.
   Web of Science ®Google Scholar
• V. Duhalde, B. Lahille, F. Camou, S. Pédeboscq, and J.-P. Pometan, “Proper Use of Antibiotics: Aprospective Study on the Use of Linezolid in a French University Hospital,” Pathologie Biologie 55, no. 10 (2007): 478–81.
   PubMedGoogle Scholar
• C. Marcireau, M. Guilloton, and F. Karst, “In Vivo Effects of Fenpropimorph on the Yeast Saccharomyces cerevisiae and Determination of the Molecular Basis of the Antifungal Property,” Antimicrobial Agents and Chemotherapy 34, no. 6 (1990): 989–93.
   PubMed Web of Science ®Google Scholar
• S.P. Sawargave, A.S. Kudale, J.V. Deore, D.S. Bhosale, J.M. Divse, S.P. Chavan, and H.B. Borate, “One-Step Synthesis of 4-Alkyl-3-Aryl-2,6-Dicyanoanilines and Their Use in the Synthesis of Highly Functionalized 2,3,5,6,7- and 2,” Tetrahedron Letters 52, no. 42 (2011): 5491–3.
   Web of Science ®Google Scholar
• F. Segat-Dioury, O. Lingibé, B. Graffe, M.-C. Sacquet, and G. Lhommet, “A General Synthesis of Enantiopure 1,2-Aminoalcohols via Chiral Morpholinones,” Tetrahedron 56, no. 2 (2000): 233–48.
   Web of Science ®Google Scholar
• A. Trabocchi, A. Krachmalnicoff, G. Menchi, and A. Guarna, “Synthesis and Conformational Studies of a Hybrid β-Alanine-Morpholine Tetramer,” Tetrahedron 68, no. 47 (2012): 9701–5.
   Web of Science ®Google Scholar
• D.P. Walker, B.M. Eklov, and M.W. Bedore, “Practical Synthesis of 3-Oxa-6-Azabicyclo[3.1.1]Heptane Hydrotosylate; a Novel Morpholine-Based Building Block,” Synthesis 44, no. 18 (2012): 2859–62.
   Web of Science ®Google Scholar
• G. Tosi, F. Zironi, E. Caselli, A. Forni, and F. Prati, “Biocatalytic Asymmetric Synthesis of (S)- and Timolol,” Synthesis 2004, no. 10 (2004): 1625–8.
   Google Scholar
• O.L. Shvaika, Osnovisintezulіkars ’kikhrechovin (Principles of Synthesis of Medicines) (Donets’k: SkhіdniiVidavn. Dіm, 2002).
   Google Scholar
• G. Assaf, G. Cansell, D. Critcher, S. Field, S. Hayes, S. Mathew, and A. Pettman, “Application of a Process Friendly Morpholine Synthesis to (S, S)-Reboxetine,” Tetrahedron Letters 51, no. 38 (2010): 5048–51.
   Web of Science ®Google Scholar
• S.P. Hanlon, A. Camattari, S. Abad, A. Glieder, M. Kittelmann, S. Lütz, B. Wirz, and M. Winkler, “Human FMO2-Based Microbial Whole-Cell Catalysts for Drug Metabolite Synthesis,” Chemical Communications 48, no. 48 (2012): 6001.
   PubMedGoogle Scholar
• Y. Tatsumi, M. Yokoo, H. Senda, and K. Kakehi, “Therapeutic Efficacy of Topically Applied KP-103 against Experimental Tinea Unguium in guinea Pigs in Comparison with Amorolfine and Terbinafine,” Antimicrobial Agents and Chemotherapy 46, no. 12 (2002): 3797–801.
   PubMed Web of Science ®Google Scholar
• D.S. Johnson and J.J. Li, Eds., The Art of Drug Synthesis (Hoboken, NJ; Canada: Wiley, 2007), 71–81.
   Google Scholar
• Q. Yang, L.G. Ulysse, M.D. McLaws, D.K. Keefe, B.P. Haney, C. Zha, P.R. Guzzo, and S. Liu, “Palladium-Catalyzed α-Arylation Reactions in Total Synthesis,” Organic Process Research and Development 2015, no. 1 (2015): 38–49.
   Google Scholar
• P.A. Burland, H.M.I. Osborn, and A. Turkson, “Synthesis and Glycosidase Inhibitory Profiles of Functionalised Morpholines and Oxazepanes,” Bioorganic and Medicinal Chemistry 19, no. 18 (2011): 5679–92.
   PubMed Web of Science ®Google Scholar
• J. Keldenich, C. Michon, A. Nowicki, and F. Agbossou-Niedercorn, “Synthesis of a Chiral Key Intermediate of Neurokinin Antagonist SSR 240600 by Asymmetric Allylic Alkylation,” Synlett 2011, no. 20 (2011): 2939–42.
   Google Scholar
• T.-X. Meìtro, A. Cochi, D.G. Pardo, and J. Cossy, “Asymmetric Synthesis of an Antagonist of Neurokinin Receptors: SSR 241586,” Journal of Organic Chemistry 76, (2011): 2594.
   PubMed Web of Science ®Google Scholar
• R.J. Lukas, A.Z. Muresan, M.I. Damaj, B.E. Blough, X. Huang, H.A. Navarro, S.W. Mascarella, J.B. Eaton, S.K. Marxer-Miller, and F.I. Carroll, “Synthesis and Characterization of in Vitro and in Vivo Profiles of Hydroxybupropion Analogues: aids to Smoking Cessation,” Journal of Medicinal Chemistry 53, no. 12 (2010): 4731–48.
   PubMed Web of Science ®Google Scholar
• X. Sun, L. Niu, X. Li, X. Lu, and F. Li, “Characterization of Metabolic Profile of Mosapride Citrate in Rat and Identification of Two New Metabolites: Mosapride N-Oxide and Morpholine Ring-Opened Mosapride by UPLC-ESI-MS/MS,” Journal of Pharmaceutical and Biomedical Analysis 50, no. 1 (2009): 27–34.
   PubMed Web of Science ®Google Scholar
• R.W. Parrott and S.R. Hitchcock, “β-Amino Alcohols Derived from (1R,2S)-Norephedrine and (1S,2S)-Pseudonorephedrine as Catalysts in the Asymmetric Addition of Diethylzinc to Aldehydes,” Tetrahedron: Asymmetry 19, no. 1 (2008): 19–26.
   Google Scholar
• D.E.A. Raup, B. Cardinal-David, D. Holte, and K.A. Scheidt, “Cooperative Catalysis by Carbenes and Lewis Acids in a Highly Stereoselective Route to Gamma-Lactams,” Nature Chemistry 2, no. 9 (2010): 766–71.
   PubMed Web of Science ®Google Scholar
• R.M. Acheson, An Introduction to the Chemistry of Heterocyclic Compound, 3rd ed. (London: Wiley, 1976), 348.
   Google Scholar
• A.K.C. Schmidt and C.B.W. Stark, “Tetrapropylammonium Perruthenate Catalyzed Glycol Cleavage to Carboxylic (di)acids,” Organic Letters 13, no. 21 (2011): 5788–91.
   PubMed Web of Science ®Google Scholar
• X.-M. Wang, M.-H. Xin, J. Xu, B.-R. Kang, Y. Li, S.-M. Lu, and S.-Q. Zhang, “Synthesis and Antitumor Activities Evaluation of m-(4-Morpholinoquinazolin-2-yl)Benzamides In Vitro and In Vivo,” European Journal of Medicinal Chemistry 96, (2015): 382–39.
   PubMed Web of Science ®Google Scholar
• L. Prescott, J. Harley, and D. Klein, Microbiology (Boston: The McGraw Hill, 2002), 16.
   Google Scholar
• A. Dalhoff, “Quinolone Resistance in Pseudomonas aeruginosa and Staphylococcus aureus. Development during Therapy and Clinical Significance,” Infection 22, no. S2 (1994): S111–S121.
   PubMed Web of Science ®Google Scholar
• D. Livermore, “Antibiotic Resistance in Staphylococci,” International Journal of Antimicrobial Agents 16, (2000): 3–10.
   PubMed Web of Science ®Google Scholar
• V. Lee and S. Hecker, “Antibiotic Resistance versus Small Molecules, the Chemical Evolution,” Medicinal Research Reviews 19, no. 6 (1999): 521–42.
   PubMed Web of Science ®Google Scholar
• M. Koca, S. Servi, C. Kirilimis, M. Ahmedzade, C. Kazaz, B. Ozbek, and G. Otuk, "Synthesis and Antimicrobial Activity of some Novel Derivatives of Benzofuran: Part 1. Synthesis and Antimicrobial Activity of (benzofuran-2-yl)(3-phenyl-3-methylcyclobutyl ketoxime Derivatives," European Journal of Medicinal Chemistry 40, (2005): 1351–1358.
   PubMed Web of Science ®Google Scholar
• R. Sharma, K. Sharma, and S. Dikshit, "Synthesis, Characterization, and Biological Activities of new 1-[(2, 3- dichloroanilinomalonyl)-3-(N-2’-cyanoethyl)-2-(N-cinnamoyl) 2, 3- dichloroanilino)]-5- phenyl pyrazoline Derivatives," Advances in Applied Science Research 2, no. 1 (2011): 178–192.
   Google Scholar
• F. Saleshier, S. Suresh, N. Anitha, and J. Karim, "Design, Docking and Synthesis of some 6-benzimidazoyl Pyrans and Screening of their Anti Tubercular Activity," European Journal of Experimental Biology 1, no. 2 (2011): 150–159.
   Google Scholar
• R. Sharma, K. Sharma, and S. Dixit, "Synthesis, Characterization and Biological Activities of some New Acidhydrazones Derived from ethyl-2-[(N-cinnamoyl)-2,3-dichloroanilido]acetohydrazide," Der Chemica Sinica 1, no. 1 (2010): 57–66.
   Google Scholar